Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Allianz SE took a bold step into biotech, scooping up over $9.9 million worth of Amgen shares in Q4. This move adds Allianz ...

A federal judge on Friday dismissed a lawsuit that challenged Colorado's power to cap prescription drug costs.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

A federal judge has dismissed Amgen’s lawsuit against Colorado’s Prescription Drug Affordability Board, allowing the state to move forward with setting price ceilings on prescription drugs, The Denver ...

These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be ...

LM Advisors LLC has injected $641,000 worth of confidence into Amgen, scooping up 2,460 shares in Q4. Several other firms ...

A federal judge has thrown out Amgen’s lawsuit against the state board empowered to set price ceilings on prescription drugs ...

Shares of Amgen and IBM are posting strong returns Monday morning, sending the Dow Jones Industrial Average into positive territory.

In the case filed by Amgen last year, U.S. District Court Judge Nina Wang ruled that a Colorado state board can proceed with plans to limit the costs for medications. This is the first court decision ...